Zura Bio Statistics Share Statistics Zura Bio has 65.02M
shares outstanding. The number of shares has increased by -2.98%
in one year.
Shares Outstanding 65.02M Shares Change (YoY) -2.98% Shares Change (QoQ) -9.51% Owned by Institutions (%) 49.07% Shares Floating 37.88M Failed to Deliver (FTD) Shares 13,696 FTD / Avg. Volume 2.17%
Short Selling Information The latest short interest is 425.34K, so 0.65% of the outstanding
shares have been sold short.
Short Interest 425.34K Short % of Shares Out 0.65% Short % of Float 0.72% Short Ratio (days to cover) 1.05
Valuation Ratios The PE ratio is -4.14 and the forward
PE ratio is -2.64.
Zura Bio's PEG ratio is
0.06.
PE Ratio -4.14 Forward PE -2.64 PS Ratio 0 Forward PS 17.9 PB Ratio 1.28 P/FCF Ratio -6.67 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Zura Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.16,
with a Debt / Equity ratio of 0.
Current Ratio 9.16 Quick Ratio 9.16 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.51M Employee Count 30 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -41.43% in the
last 52 weeks. The beta is -0.02, so Zura Bio's
price volatility has been lower than the market average.
Beta -0.02 52-Week Price Change -41.43% 50-Day Moving Average 1.82 200-Day Moving Average 1.58 Relative Strength Index (RSI) 65.16 Average Volume (20 Days) 630,628
Income Statement
Revenue n/a Gross Profit -9K Operating Income -55.19M Net Income -45.39M EBITDA -52.39M EBIT -52.4M Earnings Per Share (EPS) -0.6
Full Income Statement Balance Sheet The company has 176.5M in cash and 0 in
debt, giving a net cash position of 176.5M.
Cash & Cash Equivalents 176.5M Total Debt n/a Net Cash n/a Retained Earnings -155.9M Total Assets 157.81M Working Capital 138.29M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -28.08M
and capital expenditures -75K, giving a free cash flow of -28.15M.
Operating Cash Flow -28.08M Capital Expenditures -75K Free Cash Flow -28.15M FCF Per Share -0.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
